[Clinical efficacy of magnetic resonance electromagnetic therapy combined with Qianlie Beixi Capsules in the treatment of chronic prostatitis / chronic pelvic pain syndrome].

OBJECTIVE

To evaluate the effect and safety of the magnetic resonance electromagnetic therapy (MREM) combined with Qianlie Beixi Capsules (QBC) in the treatment of chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS).

METHODS

Using a prospective, two-center, randomized, open, positive drug-loading, parallel-controlled clinical design, we randomly divided 124 patients with CP/CPPS into a control and an observation group of equal number, the former treated with QBC and the latter with QBC combined with MREM for a course of 14 days. Then, we compared the NIH-CPSI scores before and after treatment, the total effectiveness rate and safety between the two groups of patients.

RESULTS

After treatment, the patients in both the observation and control groups showed significantly improved total and specific item scores on NIH-CPSI (P < 0.05), and those of the observation group achieved even more significant improvement than the controls either in the total NIH-CPSI score (16.65 ± 7.90 vs 21.95 ± 5.70, P < 0.05) or in the pain symptom score (7.34 ± 3.26 vs 9.50 ± 2.47, P < 0.05), urination symptom score (3.53 ± 2.56 vs 4.50 ± 2.35, P < 0.05) and quality of life score (5.94 ± 2.89 vs 8.03 ± 2.60, P < 0.05). The total effectiveness rate was remarkably higher in the observation than in the control group (83.87% vs 53.23%, P < 0.05). No adverse events or reactions were observed in either group of the patients during the trial.

CONCLUSIONS

Magnetic resonance electromagnetic therapy combined with Qianlie Beixi Capsules can significantly relieve the clinical symptoms of CP/CPPS patients with high effectiveness and safety.